3Masferrer J L,Leahy K M,Koki A T,et al.Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors[J].Cancer Res,2000,60(5):1306-1311.
4Fidler I,Ellis L M.The implications of angiogenesis for the biology and therapy of cancer metastasis[J].Cell,1994,79(2):185-188.
5Moon W S,Rhyu K H,Kang M J,et al.Overexpression of VEGF and angiopoietin 2:a key to high vascularity of hepatocellular carcinoma[J].Mod Pathol,2003,16(6):552-557.
6Yoshiji H,Kuriyama S,Yoshii J,et al.Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma[J].Hepatology,2002,35 (4):834-842.
7Maisonpierre P C,Suri C,Jones P F,et al.Angiopoientin-2,a natural antagonist tor Tie 2 that disrupts in vivo angiogenesis[J].Science,1997,277 (5322):55-60.
8Liu X H,Kirschenbaum A,Yao S,et al.Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo[J].J Urol,2000,164(3):820-835.
9Thun M J,Namboodiri M M,Heath C M.Aspirin use and reduced risk of fatal colon cancer[J].N Engl J Med,1991,325(23):1593-1596.
10Eberhart C E,Coffey R J,Radhika A,et al.Upregulation of cyclooxygcnase 2 gene expression in human colorectal adenomas and adenocarcinomas[J].Gastroenterology,1994,107(4):1183-1188.
